Supernus Pharmaceuticals | Kostnadene For Salg

Cost Of Sales Endring Dato
Abbott USD 4.46B 93M 2024-03
ANI Pharmaceuticals USD 49.16M 4.26M 2024-03
Aurora Cannabis CAD 67.36M 3.94M 2023-12
Bristol-Myers Squibb USD 2.93B 225M 2024-03
Canopy Growth CAD 57.32M 7.04M 2024-03
Corcept Therapeutics USD 2.53M 658K 2024-03
Eisai JPY 38.88B 2.45B 2023-12
Eli Lilly USD 1.67B 114.5M 2024-03
Pacira USD 47.42M 276K 2024-03
Perrigo USD 724.4M 5.2M 2024-03
Pfizer USD 3.38B 3.29B 2024-03
Supernus Pharmaceuticals USD 16.31M 3.32M 2024-03
United Therapeutics USD 72.9M 1.9M 2024-03
Xeris Pharmaceuticals USD 5.97M 1.6M 2024-03



Supernus Pharmaceuticals Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.